Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: boomertree2 who wrote (12767)	4/7/2014 10:17:22 AM
From: Mark Buczynski	2 Recommendations Recommended By Howard Williams Jack Russell Read Replies (1) \| Respond to of 13111

Your headline should read "Amgen cancer tests failed to extend life, and adds serious side effects." Gee, people might get the wrong impression about PVCT after reading your post. The write-ups on Amgen are really good news for PVCT. Adds validity and shows that a little company in Tenn has a real therapy for cancer when a larger established company can not.